Clinics in Liver Disease
Overview
Clinics in Liver Disease is a reputable medical journal that focuses on the latest advancements and research in the field of hepatology. It provides comprehensive reviews and expert insights on various liver diseases, including viral hepatitis, cirrhosis, liver cancer, and liver transplantation. With contributions from renowned clinicians and researchers, this journal serves as a valuable resource for healthcare professionals seeking to enhance their understanding and management of liver disorders.
Details
Details
Abbr.
Clin Liver Dis
Start
1997
End
Continuing
Frequency
Quarterly
p-ISSN
1089-3261
e-ISSN
1557-8224
Country
United States
Language
English
Specialty
Gastroenterology
Metrics
Metrics
h-index / Ranks: 3442
94
SJR / Ranks: 4256
934
CiteScore / Ranks: 3240
6.60
JIF / Ranks: 1521
5.1
Recent Articles
1.
2.
Khalid M, Likhitsup A, Parikh N
Clin Liver Dis
. 2024 Nov;
29(1):87-103.
PMID: 39608960
Embolic and ablative locoregional therapies (LRTs) for hepatocellular carcinoma are widely used to cure, bridge, or downstage patients for more definitive therapies. Common ablative therapies include microwave ablation and radiofrequency...
3.
Jakhete N, Majeed N, Maluf D, Shetty K
Clin Liver Dis
. 2024 Nov;
29(1):73-85.
PMID: 39608959
Liver transplantation (LT) is the standard-of-care for early hepatocellular carcinoma (HCC). Current selection criteria depend primarily on measures of tumor burden and alpha-fetoprotein levels. Evolving strategies include the application of...
4.
Tabrizian P, Pero A, Schwartz M
Clin Liver Dis
. 2024 Nov;
29(1):59-72.
PMID: 39608958
Hepatic resection has long been considered the preferred treatment for hepatocellular carcinoma (HCC) when feasible, but its role, as well as the outcomes is evolving rapidly. This article explores the...
5.
Zheng E, Yao F
Clin Liver Dis
. 2024 Nov;
29(1):49-58.
PMID: 39608957
In the setting of hepatocellular carcinoma (HCC) surveillance, a range of observations can be identified. Often, imaging findings and biochemical results are consistent with the diagnosis of HCC. However, challenges...
6.
Vutien P, Kim N, Nguyen M
Clin Liver Dis
. 2024 Nov;
29(1):33-48.
PMID: 39608956
Promoting the early detection and diagnosis of hepatocellular carcinoma (HCC) is a critical strategy to improve patient outcomes as this can lead to greater access to curative treatments. This review...
7.
Roberts L
Clin Liver Dis
. 2024 Nov;
29(1):17-31.
PMID: 39608955
This article reviews surveillance for the detection of early stage hepatocellular carcinoma, covering the rationale for surveillance, optimal selection of persons needing surveillance, methods and frequency of screening, strategies for...
8.
Mohy-Ud-Din N, Babich M
Clin Liver Dis
. 2024 Nov;
29(1):149-156.
PMID: 39608954
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver, and 85% to 90% of cases of HCC occur in patients with underlying liver disease. This makes it...
9.
Henry Z, Argo C
Clin Liver Dis
. 2024 Nov;
29(1):135-147.
PMID: 39608953
Management of cirrhosis sequelae is critical in providing the most options for patients with hepatocellular carcinoma (HCC). Compensated liver disease is the ideal state for HCC patients who may require...
10.
Travers J, Mahipal A, Chotai P, Gholam P
Clin Liver Dis
. 2024 Nov;
29(1):125-133.
PMID: 39608952
Hepatocellular carcinoma (HCC) presentation reflects a complex interaction between cancer stage, severity of liver disease, and overall functional status. This article provides clinical vignettes that illustrate these complex interactions and...